1801 — Innovent Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapMomentum Trap

Annual balance sheet for Innovent Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	8,048	7,948	8,265	10,120	7,884
Net Total Accounts Receivable
Net Total Receivables	475	968	575	1,006	1,184
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9,467	11,551	11,507	13,428	10,273
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,183	3,376	4,061	4,852	5,794
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	11,835	16,244	17,589	20,627	21,603
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,486	3,050	3,499	4,477	4,369
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3,055	5,913	6,859	8,100	8,485
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	8,780	10,330	10,730	12,528	13,118
Total Liabilities & Shareholders' Equity	11,835	16,244	17,589	20,627	21,603
Total Common Shares Outstanding